{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:33Z","timestamp":1784557053632,"version":"3.55.0"},"reference-count":11,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,7]]},"abstract":"<jats:p>We describe a case of severe erythrocytosis caused by testosterone replacement therapy in a 66-year-old man affected with hypogonadotropic hypogonadism (HH) determining osteoporosis, resolved by switching to restoration therapy with clomiphene citrate. The patient complained fatigue, loss of libido and defective erections and a spontaneous vertebral fracture despite bisphosphonate therapy and vitamin D supplementation. The examinations proved isolated HH and he was therefore treated with testosterone gel with regression of specific manifestations but elevated hemoglobin and hematocrit values. Therefore, it was decided to switch to a restoration therapy with clomiphene citrate 25\u2009mg\/die, which resulted in the resolution of symptoms without evident side effects. In a couple of months, the patient showed normalization of testosterone levels and increment of testicular volume. Since secondary hypogonadism is the consequence of an insufficient stimulation of the gonads by hypothalamic\u2013pituitary axis, therapeutic approaches aimed to restore endogenous testosterone production should be considered in alternative to testosterone replacement, particularly if side effects intervene. Among these strategies, clomiphene citrate seems to have a high efficacy and safety profile also in the elderly with isolated HH and no evident pituitary lesion.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points:<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Hypogonadism should always be assessed in patients with severe loss in BMD and undergo appropriate medical treatment.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>In hypogonadotropic hypogonadism, more approaches are available other than testosterone replacement therapy alone.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>In patients with severe late-onset central hypogonadism presenting with erythrocytosis even at low doses of replacement therapy, restoration therapy with clomiphene could prove to be an effective solution, particularly in patients with a reversible disruption of GNRH\/gonadotropin functions.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Clomiphene citrate increases gonadotropin levels and testicular volume and should therefore be considered in hypogonadal men who wish to remain fertile.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-17-0055","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T07:36:30Z","timestamp":1499412990000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":4,"title":["Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis"],"prefix":"10.1530","volume":"2017","author":[{"given":"B","family":"Cangiano","sequence":"first","affiliation":[{"name":"1Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Italy"},{"name":"2Department of Clinical Sciences and Community Health, University of Milan, Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"1Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Italy"},{"name":"2Department of Clinical Sciences and Community Health, University of Milan, Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Persani","sequence":"additional","affiliation":[{"name":"1Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Italy"},{"name":"2Department of Clinical Sciences and Community Health, University of Milan, Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bonomi","sequence":"additional","affiliation":[{"name":"1Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Italy"},{"name":"2Department of Clinical Sciences and Community Health, University of Milan, Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"key20170711125525513_bib1","first-page":"223","article-title":"The complex genetic basis of congenital hypogonadotropic hypogonadism","volume":"41","author":"Vezzoli","year":"2016","journal-title":"Minerva Endocrinologica"},{"key":"key20170711125525513_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.2009-1796","article-title":"Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study","volume":"95","author":"Tajar","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"key20170711125525513_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.fertnstert.2013.09.003","article-title":"Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters","volume":"101","author":"Samplaski","year":"2014","journal-title":"Fertility and Sterility"},{"key":"key20170711125525513_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/CIA.S1609","article-title":"Testosterone replacement therapy for older men","volume":"2","author":"Borst","year":"2007","journal-title":"Clinical Interventions in Aging"},{"key":"key20170711125525513_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point","volume":"69","author":"Bachman","year":"2014","journal-title":"Journals of Gerontology: Series A, Biological Sciences and Medical Sciences"},{"key":"key20170711125525513_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"key20170711125525513_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/1008-682X.143736","article-title":"Alternatives to testosterone replacement: testosterone restoration","volume":"17","author":"McCullough","year":"2015","journal-title":"Asian Journal of Andrology"},{"key":"key20170711125525513_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14728214.2012.683411","article-title":"Emerging medication for the treatment of male hypogonadism","volume":"17","author":"Corona","year":"2012","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"key20170711125525513_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2012.10968.x","article-title":"Clomiphene citrate is safe and effective for long-term management of hypogonadism","volume":"110","author":"Moskovic","year":"2012","journal-title":"BJU International"},{"key":"key20170711125525513_bib10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/jcem-65-6-1118","article-title":"The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate","volume":"65","author":"Tenover","year":"1987","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"key20170711125525513_bib11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bju.13546","article-title":"Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels","volume":"118","author":"Chandrapal","year":"2016","journal-title":"BJU International"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2017\/1\/EDM17-0055.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2017\/1\/EDM17-0055.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:36Z","timestamp":1784555196000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":11,"URL":"https:\/\/doi.org\/10.1530\/edm-17-0055","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]}}}